Further, deletion of the bulk CD4+ T cell population allowed for long-lived antigen-specific CD8+ T cells in secondary lymphoid organs and were protective after primary tumor resection against both localized and systemic secondary tumor challenges. This evidence concerns the gene CD8A and neoplasm.